Free Trial
ASX:BNO

Bionomics (BNO) Stock Price, News & Analysis

About Bionomics Stock (ASX:BNO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
386,458 shs
Average Volume
N/A
Market Capitalization
A$13.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionomics and its competitors with MarketBeat's FREE daily newsletter.

BNO Stock News Headlines

Bionomics Stock Price History
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Bionomics ADR (BNOX) Earnings Dates & Reports
See More Headlines

BNO Stock Analysis - Frequently Asked Questions

Bionomics Limited (ASX:BNO) posted its quarterly earnings results on Friday, February, 15th. The company reported ($0.02) earnings per share for the quarter. Bionomics had a negative net margin of 14,558.34% and a negative trailing twelve-month return on equity of 116.12%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bionomics investors own include McDermott International (MDR), Pacific Drilling (PACDQ), OreCorp (ORR), ORBCOMM (ORBC), Lithium Power International (LPI), Lithium Australia (LIT) and CocaCola (KO).

Company Calendar

Last Earnings
2/15/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:BNO
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$24.91 million
Net Margins
-14,558.34%
Pretax Margin
N/A
Return on Equity
-116.12%
Return on Assets
-20.98%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
3.30
Quick Ratio
12.02

Sales & Book Value

Annual Sales
A$6.02 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.69
Book Value
A$1.09 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Market Cap
A$13.22 million
Optionable
Not Optionable
Beta
2.13
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (ASX:BNO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners